Screener
Janux Therapeutics JANX Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Janux Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:ProfitLoss.
The source filing: Janux Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:18 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338078
FAQ
- What is Janux Therapeutics's net income?
- Janux Therapeutics (JANX) reported net income of -$21.97M in Q2 2026.
- How has Janux Therapeutics's net income changed year-over-year?
- Janux Therapeutics's net income increased by 35.1% year-over-year, from -$33.86M to -$21.97M.
- What is the long-term trend for Janux Therapeutics's net income?
- Over 4 years (2021 to 2025), Janux Therapeutics's net income has grown at a 36.6% compound annual growth rate (CAGR), from -$32.67M to -$113.63M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Janux Therapeutics's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude